Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea

Genes Chromosomes and Cancer

Volumn 46, Issue 2, 2007, Pages 130-142

  Narath, R ^a,c   Ambros, I M ^a   Kowalska, A ^a   Bozsaky, E ^a   Boukamp, P ^b   Ambros, Peter F ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; HERMES ANTIGEN; HYDROXYUREA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MOLECULAR MARKER; SENESCENCE ASSOCIATED BETA GALACTOSIDASE; TELOMERASE;

ARTICLE; CANCER GENETICS; CANCER RESEARCH; CELL AGING; CELL GRANULE; CELL LINE; CELL STRUCTURE; CHROMOSOME; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GENE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MICRONUCLEUS; MYCN GENE; NEUROBLASTOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TELOMERE; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL AGING; CELL LINE, TUMOR; GENE AMPLIFICATION; HUMANS; HYDROXYUREA; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS;

EID: 33845491676     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20393     Document Type: Article

References (48)

1. Ambros IM, Ambros PF. 2000. The role of Schwann cells in neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, Voute PA, editors. Neuroblastoma. Elsevier, The Netherlands, pp. 229-243.
2. Ambros IM, Rumpler S, Luegmayr A, Hattinger CM, Strehl S, Kovar H, Gadner H, Ambros PF. 1997. Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation-Sign of tumour cell revertance? Eur J Cancer 33:2043-2049.
3. Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D, Gadner H, Ambros PF. 1996. Role of ploidy, chromosome 1p, and Schwann cells in ehe maturation of neuroblascoma. N Engl J Med 334:1505-1511.
4. Ambros PF, Mehes G. 2003. Combined immunofluorescence and FISH: New prospects for tumor cell detection/identification. In: Robinson JP, Darzynkiewicz Z, Hyun W, Orfao A, Rabinovitch P, editors. Current Protocols in Cytometry. New York: Wiley, pp. 8.13.1-8.13.10.
5. Bertram MJ, Berube NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, Spurgers K, Bick RJ, Baldini A, Ning Y, Clark LJ, Parkinson EK, Barrett JC, Smith JR, Pereira-Smith OM. 1999. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol 19:1479-1485.
6. Biedler JL, Helson L, Spengler BA. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
7. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
8. Canute GW, Longo SL, Longo JA, Winfield JA, Nevaldine BH, Hahn PJ. 1996. Hydroxyurea accelerates the loss of epidermal growth factor receptor genes amplified as double-minute chromosomes in human glioblastoma multiform. Neurosurgery 39:976-983.
9. Cerezo A, Kalthoff H, Schuermann M, Schafer B, Boukamp P. 2002. Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 115:1305-1312.
10. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. 2002. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 99:389-394.
11. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN. 1995. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92:4337-4341.
12. Christen RD, Shalinsky DR, Howell SB. 1992. Enhancement of the loss of multiple drug resistance by hydroxyurea. Semin Oncol 19:94-100.
13. Corvi R, Amler LC, Savelyeva L, Gehring M, Schwab M. 1994. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci USA 91:5523-5527.
14. Dimri GP. 2005. What has senescence got to do with cancer? Cancer Cells 7:505-512.
15. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367.
16. Dimri GP, Testori A, Acosta M, Campisi J. 1996. Replicative senescence, aging and growth-regulatory transcription factors. Biol Signals 5:154-162.
17. Freeman-Edward J, O'Neill S, Lastowska M, Bown N. 2000. Expulsion of amplified MYCN from neuroblastoma tumor cells. Cancer Genet Cytogenet 116:87, 88.
18. Fusenig NE, Boukamp P. 1998. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 23:144-158.
19. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
20. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614-636.
21. Hayflick L. 1997. Mortality and immortality at the cellular level. A review. Biochemistry (Mosc) 62:1180-1190.
22. Hayflick L, Moorhead PS. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621.
23. Hunt JD, Valentine M, Tereba A. 1990. Excision of N-myc from chromosome 2 in human neuroblastoma cells containing amplified N-myc sequences. Mol Cell Biol 10:823-829.
24. Hwang ES. 2002. Replicative senescence and senescence-like state induced in cancer-derived cells. Mech Ageing Dev 123:1681-1694.
25. Kahlem P, Dorken B, Schmitt CA. 2004. Cellular senescence in cancer treatment: Friend or foe? J Clin Invest 113:169-174.
26. Kanda T, Otter M, Wahl GM. 2001. Mitotic segregation of viral and cellular acentric extrachromosomal molecules by chromosome tethering. J Cell Sci 114:49-58.
27. Kurz DJ, Decary S, Hong Y, Erusalimsky JD. 2000. Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113:3613-3622.
28. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD. 2004. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 117:2417-2426.
29. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, Dirks RW, Raap AK, Tanke HJ. 1996. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5:685-691.
30. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. 2000. Genes involved in senescence and immortalization. Curr Opin Cell Biol 12:705-709.
31. Narath R, Lorch T, Greulich-Bode KM, Boukamp P, Ambros PF. 2005. Automatic telomere length measurements in interphase nuclei by IQ-FISH. Cytometry A 68:113-120.
32. Narath R, Lorch T, Rudas M, Ambros PF. 2004. Automatic quantification of gene amplification in clinical samples by IQ-FISH. Cytometry B 57:15-22.
33. Parrinello S, Coppe JP, Krtolica A, Campisi J. 2005. Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118:485-496.
34. Roninson IB. 2003. Tumor cell senescence in cancer treatment. Cancer Res 63:2705-2715.
35. Ross RA, Spengler BA, Biedler JL. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-747.
36. Shay JW, Roninson IB. 2004. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919-2933.
37. Shay JW, Wright WE. 2001. Ageing and cancer: The telomere and telomerase connection. Novartis Found Symp 235:116-125.
38. Snapka RM, Varshavsky A. 1983. Loss of unstably amplified dihydrofolate reductase genes from mouse cells is greatly accelerated by hydroxyurea. Proc Natl Acad Sci USA 80:7533-7537.
39. Spengler BA, Lazarova DL, Ross RA, Biedler JL. 1997. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res 9:467-476.
40. Tominaga K, Olgun A, Smith JR, Pereira-Smith OM. 2002. Genetics of cellular senescence. Mech Ageing Dev 123:927-936.
41. Trent JM, Thompson FH, Ludwig C. 1984. Evidence for selection of homogeneously staining regions in a human melanoma cell line. Cancer Res 44:233-237.
42. Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE. 1970. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30:2110-2118.
43. Valent A, Benard J, Clausse B, Barrois M, Valteau-Couanet D, Terrier-Lacombe MJ, Spengler B, Bernheim A. 2001. In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol 158:1579-1584.
44. Van Roy N, Vandesompele J, Menten B, Nilsson H, De Smet E, Rocchi M, De Paepe A, Pahlman S, Speleman F. 2006. Translocation-excision-deletion- amplification mechanism leading to non-syntenic coamplification of MYC and ATBF1. Genes Chromosomes Cancer 45:107-117.
45. Von Hoff DD, McGill JR, Forseth BJ, Davidson KK, Bradley TP, Van Devanter DR, Wahl GM. 1992. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA 89:8165-8169.
46. Von Hoff DD, Waddelow T, Forseth B, Davidson K, Scott J, Wahl G. 1991. Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells. Cancer Res 51:6273-6279.
47. Wainwright LJ, Lasorella A, Iavarone A. 2001. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 98:9396-9400.
48. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, Herron GS. 1999. Human endothelial cell life extension by telomerase expression. J Biol Chem 274:26141-26148.